Year: 2018
Type: article
Abstract: Schizophrenia is a psychiatric disorder characterized by delusions,hallucinations, unorganized behavior, negative symptoms,and social dysfunction. Treatment of schizophrenic patientsincludes pharmacological and psychosocial treatments. Althoughantipsychotic drugs constitute the basis of pharmacologicaltreatment, research dealing with schizophrenia has shown thatpsychosocial approaches accelerate clinical improvement.Psychosocial approaches should be supported and integratedwith drug therapy. Most schizophrenia patients benefit from theapproaches in combination of antipsychotics and psychosocialtreatment. Epidemiological studies have shown that there is adifference in gender, the most frequent age range is 15-25 yearsfor males while 25-35 years for females and schizophrenia ismore frequent in families with low socioeconomic status. Inetiological studies, schizophrenia has been explained by geneticfactors, brain structural changes, neurochemical changes,neurophysiological changes and endocrinal factors. It has beensuggested that 4 basic symptoms of schizophrenia are association,ambivalence, autism (autism) and affection. Schizophreniais divided into five subtypes as paranoid, disorganized, catatonic,undifferentiated and residual by considering clinical results.Schizophrenia is a chronic disease that affects patients' dailylives. The goal of the treatment is to reduce or eliminate thesymptoms, increase the quality of life and make life adaptableto the patient and reduce the destructive effects of the diseaseas much as possible.
Source: DergiPark (Istanbul University)
Institution: Istanbul University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4289744130